Literature DB >> 2144977

Corticosteroids increase lipocortin I in alveolar epithelial cells.

M P Ambrose1, G W Hunninghake.   

Abstract

Lipocortin I mediates, in part, the anti-inflammatory effects of corticosteroids. To determine whether alveolar epithelial cells produce lipocortin I, we used a highly specific anti-lipocortin I antibody and found by the techniques of Western blotting and immunocytochemical analysis that lipocortin I is a normal constituent of type II alveolar epithelial cells and that it constitutes approximately 0.1% of cell lysate proteins. Two separate species of lipocortin I were identified, migrating with molecular weights of 37 and 32 kD. Dexamethasone caused a dose-dependent increase in lipocortin I in rat alveolar epithelial cells, and its effect was maximal at a dose of 10(-5) M. This effect was specific for corticosteroids since it was not seen with other steroids. These studies suggest that lipocortin I may mediate, in part, the immunosuppressive effects of corticosteroids in the lower respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144977     DOI: 10.1165/ajrcmb/3.4.349

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  14 in total

1.  Mainstream and sidestream cigarette smoke exposure increases Ca2+-dependent phospholipid binding proteins in guinea pig alveolar type II cells.

Authors:  Salil K Das; Francis H C Tsao; Shyamali Mukherjee
Journal:  Mol Cell Biochem       Date:  2002-02       Impact factor: 3.396

2.  Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface.

Authors:  E Solito; H C Christian; M Festa; A Mulla; T Tierney; R J Flower; J C Buckingham
Journal:  FASEB J       Date:  2006-05-23       Impact factor: 5.191

3.  CFTR inhibition provokes an inflammatory response associated with an imbalance of the annexin A1 pathway.

Authors:  Jesmond Dalli; Guglielmo Rosignoli; Richard P G Hayhoe; Aleksander Edelman; Mauro Perretti
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

4.  Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy.

Authors:  Mattia Quattrocelli; David Y Barefield; James L Warner; Andy H Vo; Michele Hadhazy; Judy U Earley; Alexis R Demonbreun; Elizabeth M McNally
Journal:  J Clin Invest       Date:  2017-05-08       Impact factor: 14.808

5.  Measurement of lipocortin 1 levels in murine peripheral blood leukocytes by flow cytometry: modulation by glucocorticoids and inflammation.

Authors:  M Perretti; R J Flower
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

6.  Effect of annexin-1 on experimental autoimmune encephalomyelitis (EAE) in the rat.

Authors:  I Huitinga; J Bauer; P J Strijbos; N J Rothwell; C D Dijkstra; F J Tilders
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

7.  Glucocorticoid-and non-glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leucocytes in vivo.

Authors:  S H Peers; F Smillie; A J Elderfield; R J Flower
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

8.  The local anti-inflammatory action of dexamethasone in the rat carrageenin oedema model is reversed by an antiserum to lipocortin 1.

Authors:  G S Duncan; S H Peers; F Carey; R Forder; R J Flower
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

9.  Annexin A1 induces skeletal muscle cell migration acting through formyl peptide receptors.

Authors:  Valentina Bizzarro; Raffaella Belvedere; Fabrizio Dal Piaz; Luca Parente; Antonello Petrella
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

10.  Reduction of nitric oxide release from alveolar macrophages by a lipocortin peptide.

Authors:  A M Kamal; T D Tetley; I R Witherden; S F Smith
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.